Five-Year Survival for Pancreatic Cancer Has Risen to 13%
Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
THURSDAY, Jan. 18, 2024 -- Pancreatic cancer is known as a 'silent killer' because it's usually only detected in its later stages.
But there's a glimmer of good news for patients: The five-year survival rate for people with the disease has crept up to 13%, according to 2024 statistics from the American Cancer Society released Wednesday.
That's more than double the 6% five-year survival rate of a decade ago, noted experts at Pancreatic Cancer Action Network (PanCAN).
The organization credits the improvement to better detection and management of patients with cancers that have not spread beyond the pancreas.
“We have seen better management of people who are considered high risk and better survival of those with localized disease, most likely due to the increased use and improvements in treatments available before [neoadjuvant] and after [adjuvant] surgery,” Lynn Matrisian, PanCAN’s chief science officer, said in an an organization news release.
All of this is “good news," said PanCAN President and CEO Julie Fleshman, who added that, "We are seeing more patients being diagnosed at earlier stages and they are living longer."
However, the latest ACS numbers predict that about 66,400 Americans will receive the grim news this year that they have pancreatic cancer. Another 51,750 are expected to die from the illness in 2024.
Both of those numbers reflect a rise in new cases and deaths.
So, despite the uptick in five-year survival, "not enough progress is being made for patients diagnosed with metastatic disease and we need to continue to find better treatment options for those patients," Fleshman said.
Pancreatic cancer also appears to be on the rise among younger women, PanCAN noted. That could be tied to rising obesity rates and changes in racial/ethnic demographics.
"PanCAN’s research priorities are to find an early detection strategy and accelerate treatments for [pancreatic cancer] patients. And we are dedicated to increasing awareness of symptoms and risk factors of pancreatic cancer," Matrisian said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-18 22:15
Read more
- Use of Fan, Skin Wetting Reduces Cardiac Strain in Hot, Humid Conditions
- Biden Administration Uses Wartime Powers to Help Restart IV Fluid Plant in North Carolina
- Wayfinding Task on Smartphone Can Detect Subjective Cognitive Decline
- Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety
- FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
- Scientists Track Brain Function as Folks Watch Movies
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions